finance
Biotech Boom 2026: How New Valuation Playbooks Reveal Billion‑Dollar ROI Opportunities
In 2026, the biotech sector is heating up as investors who previously viewed it as a cold market now see clear pathways to high-yield returns. New valuation frameworks translate scientific milestones into concrete ROI, making biotech a prime target for capital allocation. Market Dynamics 2026 * Rebound in venture capital after